RP Bio Inc. (KOSDAQ:314140)
South Korea
· Delayed Price · Currency is KRW 6,050.00
+160.00 (2.72%)
At close: Mar 25, 2025, 3:30 PM KST
RP Bio Market Cap
RP Bio has a market cap or net worth of 46.45 billion as of April 1, 2025. Its market cap has decreased by -41.36% in one year.
Market Cap
46.45B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6,050.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 46.45B, a decrease of -67.56%. That is a compound annual growth rate of -36.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 46.45B | 6.14% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 380.67T |
| SK hynix | 131.40T |
| LG Energy Solution | 78.27T |
| Samsung Biologics | 72.17T |
| Hyundai Motor Company | 43.02T |
| Kia Corporation | 36.34T |
| Celltrion | 36.29T |
| KB Financial Group | 29.30T |